0001179110-21-000881.txt : 20210127 0001179110-21-000881.hdr.sgml : 20210127 20210127164409 ACCESSION NUMBER: 0001179110-21-000881 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210125 FILED AS OF DATE: 20210127 DATE AS OF CHANGE: 20210127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kessler Jon CENTRAL INDEX KEY: 0001615062 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 21560472 MAIL ADDRESS: STREET 1: 15 W. SCENIC POINTE DR., STE. 100 CITY: DRAPER STATE: UT ZIP: 84020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 4 1 edgar.xml FORM 4 - X0306 4 2021-01-25 0 0001428336 HEALTHEQUITY, INC. HQY 0001615062 Kessler Jon 15 WEST SCENIC POINTE DRIVE, SUITE 100 DRAPER UT 84020 1 1 0 0 President and CEO Common Stock 2021-01-25 4 S 0 54858 84.4595 D 350857 D Common Stock 2021-01-25 4 S 0 56141 85.0581 D 294716 D Common Stock 2021-01-25 4 S 0 21448 86.1154 D 273268 D Common Stock 2021-01-25 4 S 0 17553 87.1275 D 255715 D Stock Option (right to buy) 41.28 2027-03-27 Common Stock 17410 34820 I by GKF, LLC Stock Option (right to buy) 61.72 2028-03-27 Common Stock 11965 23930 I by GKF, LLC Stock Option (right to buy) 73.61 2029-03-26 Common Stock 12782 12782 I by GKF, LLC Stock Option (right to buy) 14.00 2024-07-30 Common Stock 160000 160000 I by GKF, LLC Stock Option (right to buy) 41.28 2027-03-27 Common Stock 34819 17409 D Stock Option (right to buy) 61.72 2028-03-27 Common Stock 35894 23929 D Stock Option (right to buy) 73.61 2029-03-26 Common Stock 51125 38343 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4), and (5) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.75 to $85.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.75 to $86.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.76 to $87.58, inclusive. The option is immediately exercisable. The option will become exercisable as to 17,409 shares on March 27, 2021. The option will become exercisable as to 11,965 shares on March 27, 2021 and 11,964 shares on March 27, 2022. The option will become exercisable in annual installments of 12,781 shares on each of March 26, 2021, 2022 and 2023. /s/ Jon Kessler 2021-01-26